Login
$RDY
$14.13 -$0.04 (0.28%) Close

Ownership

13F as of Q2 2026 · 834.7M shares outstanding

Who owns RDY?

By type of holder
Institutions 15.0% Insiders 0.0% Everyone else 85.0%
Concentration Top 10 holders own 73.6%
K. Satish Reddy 13.6% · G.V. Prasad 13.0%
Institutional ownership
15.0%
+0.6 pts vs last qtr
Institutional holders
239
-11 vs last qtr
Net shares bought
+5.1M
by institutions in Q2 2026
New / sold out
30 / 41
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Nuveen, LLC NEW +2.8M
  • Morgan Stanley +1.6M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BlackRock, Inc. −1.0M
  • Royal Bank Of Canada −770.8K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Dr Reddy's Laboratories Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2018–FY2026
+0.3%
+0.04% a year
Each share's claim on the business
−0.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $4.09B
over 9 fiscal years
Diluted shares, split-adjusted
805.5M824.0M842.5M2018: 830.9M shares'182019: 831.0M shares'192020: 830.4M shares'202021: 831.6M shares'212022: 831.7M shares'222023: 831.9M shares'232024: 833.5M shares'242025: 834.2M shares'252026: 833.3M shares'26
Buybacks Stock-based comp
$0$296.0M$592.0M2018 buybacks: $02018 stock comp: $454.0M'182019 buybacks: $02019 stock comp: $389.0M'192020 buybacks: $02020 stock comp: $521.0M'202021 buybacks: $02021 stock comp: $584.0M'212022 buybacks: $02022 stock comp: $592.0M'222023 buybacks: $02023 stock comp: $397.0M'232024 buybacks: $02024 stock comp: $407.0M'242025 buybacks: $02025 stock comp: $424.0M'252026 buybacks: $02026 stock comp: $326.0M'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years57% 3–5 years20% 1–3 years13% Under 1 year10%
Quarterly turnover
8.7%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting RDY on Form 13F
RI
Robeco Institutional Asset Management B.V.
Shares
18.0M
% of company
2.16%
Change vs last qtr
+843.2K (+4.9%)
Held since
2022
B
BlackRock, Inc.
Shares
10.6M
% of company
1.27%
Change vs last qtr
−1.0M (−8.6%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Dr Reddy's Laboratories Ltd, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting RDY on Form N-PORT; together they hold 2.1% of the company
AE
Position value
$53.9M
% of company
0.45%
% of the fund
2.54%
As of
June 30, 2026
Position value
$29.4M
% of company
0.24%
% of the fund
0.02%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Dr Reddy's Laboratories Ltd and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
KS
K. Satish Reddy
5%+ holder13D · 13.6%
Shares
113.4M
% of company
13.58%
Change vs last qtr
—
Held since
—
GP
G.V. Prasad
5%+ holder13D · 13.0%
Shares
108.8M
% of company
13.04%
Change vs last qtr
—
Held since
—

4 more holders behind a free account

See every insider and 5%+ holder of Dr Reddy's Laboratories Ltd.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support